News
More new healthcare solutions from BD expected at 6th CIIE Release date： 2023-07-20 Source：Multiple
Gong Zheng, mayor of Shanghai, meets Tom Polen, chairman, president, and chief executive officer of BD, in Shanghai on July 18. [Photo/WeChat account: shanghaifabu]
Shanghai Mayor Gong Zheng welcomed US medical technology company Becton, Dickinson and Company (BD) to bring more new products, technologies and services to Shanghai and China through the sixth China International Import Expo during his meeting with Tom Polen, chairman, chief executive officer and president of BD, on July 18.
Gong said that biomedicine is a leading industry in Shanghai. He added that the favorable environment for biomedicine in Shanghai as well as the institutional innovations in the Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone will create more investment, market and development opportunities for various enterprises including BD.
Polen said that BD has been impressed by Shanghai's superior environment, enormous development potential, and abundant talents over the past 30 years.
He added that the company will deepen its research and development and increase its investment in Shanghai to contribute to the city's efforts in becoming a highland for the pharmaceutical industry.
BD is presently one of the top three players in the global medical device industry and has the most extensive product lines. It has set up its Greater China headquarters as well as an innovation design center in Shanghai.
Source: WeChat account: shanghaifabu
By Zhao Guangmei
The China International Import Expo Bureau (hereinafter referred to as the "CIIE Bureau") cites or reposts media reports for non-commercial purposes to facilitate information sharing. Such actions do not constitute an endorsement of the accuracy, authenticity, or legality of the original content, nor do they reflect the official stance of the CIIE Bureau. All copyrights and legal responsibilities for the reposted content remain with the original publishers and authors.
If any individual or entity believes that content shared on this website infringes their legitimate rights and interests, please promptly notify us in writing, providing detailed explanations, supporting documentation, and rationale. Upon receiving such materials, we will promptly remove or rectify the disputed content or take other appropriate measures.
Reposted or cited information may be time-sensitive. Users are advised to exercise independent judgment regarding the accuracy and completeness of the content. The CIIE Bureau shall not be liable for any direct, indirect, incidental, consequential, special, punitive, or exemplary damages arising from the use of or inability to use the information or links provided on this website.。
The CIIE Bureau respects intellectual property rights and is committed to delivering high-quality content services within a lawful and compliant framework.